Continuous intravenous infusion of furosemide resulted in similar 24-hour total diuresis and natriuresis compared to bolus administration in 8 patients with severe heart failure.
RCT (n=8)
cross-over
Does continuous intravenous infusion of furosemide improve diuresis and reduce neurohormonal activation compared to bolus injection in patients with severe heart failure?
In patients with severe heart failure, continuous infusion and bolus injection of furosemide are equally effective for 24-hour diuresis and natriuresis, with similar neurohormonal activation profiles.
Previous studies have demonstrated that continuous infusion of furosemide results in increased diuresis and natriuresis compared with bolus administration of the drug in patients with severe heart failure. We reasoned that continuous infusion of furosemide caused less activation of neurohumoral mechanisms, since other studies have shown that bolus administration of furosemide may activate this system. We therefore tested the hypothesis that continuous administration of furosemide would increase water and sodium excretion due to less activation of neurohormones. Eight patients with severe heart failure were studied during continuous infusion over 24 h and bolus injections of furosemide twice daily in a randomized cross-over study. Bolus administration of furosemide increased diuresis and natriuresis significantly in the first 4 h after administration compared with continuous administration, but this was later reversed, resulting in similar 24 h total output. The neurohormones measured at baseline were all markedly elevated. Neither regimens of furosemide caused any further significant changes in neurohumoral response except that pro-ANF decreased more during the first 8 h after bolus administration compared to continuous infusion. This study has demonstrated that bolus administration of furosemide in conventional doses is equally effective as continuous intravenous infusion in patients with severe heart failure. This may be due to maximal neurohormonal activation in severe heart failure (NYHA III-IV) which could not be further activated by bolus administration.
Aaser et al. (Wed,) conducted a rct in severe congestive heart failure (n=8). continuous infusion of furosemide vs. bolus injections of furosemide twice daily was evaluated on 24 h total output (diuresis and natriuresis) and neurohumoral response. Continuous intravenous infusion of furosemide resulted in similar 24-hour total diuresis and natriuresis compared to bolus administration in 8 patients with severe heart failure.